# Baxter Healthcare Corporation – FDA Inspection, Jun 27, 2012

Source: https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/a52492e5-c003-4f6b-aa7e-b0624d316421
Source feed: FDA_Inspections

> FDA inspection 789123 of Baxter Healthcare Corporation, June 27, 2012. Classification: Official Action Indicated (OAI). 2 citations under 21 CFR part 211. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 789123
- Company Name: Baxter Healthcare Corporation
- Inspection Date: 2012-06-27
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1284446 - 2025-09-29](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/bca90a34-d045-41e0-8c4a-1c7913aa79df)
- FDA Inspection 1210861 - 2023-07-14
- [FDA Inspection 1072203 - 2018-11-20](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c9feb4e5-d47a-4f96-b8b4-93ff0d859b9d)
- FDA Inspection 1010362 - 2017-03-29
- FDA Inspection 983354 - 2016-04-27

Company: https://www.keypedia.com/companies/baxter-healthcare-corporation/738590ab-c241-4de1-aaec-722e154bfc45

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
